Hikal hits upper circuit after it signs a multi-year deal

By Pawan Nahar8 days ago

NEW DELHI: Shares of smallcap firm



hit the upper circuit limit and touched a 52-week high of Rs 313 on Wednesday morning after the lifesciences firm said it signed a 10-year deal with a global pharmaceutical company for development and supply of a portfolio of niche active pharmaceutical ingredients (

Continue read on indiatimes.com